Gufic Group Executive and Leadership Team

Devkinandan Roonghta, the Chief Financial Officer at Gufic Group, manages the fiscal health and capital allocation strategies for the entire organization. Overseeing financial planning and analysis, the Chief Financial Officer ensures the availability of resources for research and development initiatives. This leadership role involves monitoring market trends to guide investment in new antiviral and antibiotic product lines. By maintaining robust financial controls, Devkinandan Roonghta secures the long-term stability required for international expansion efforts. The Chief Financial Officer coordinates with the Board to align budgetary priorities with the overarching mission of delivering high-quality medical solutions. Through precise management of corporate assets and revenue streams, the Chief Financial Officer supports the scaling of operations across the Indian healthcare sector. This strategic financial oversight enables the company to sustain growth while navigating the complexities of the global pharmaceutical industry.

Nagesh Yarrabathina, the Chief Operating Officer at Gufic Group, directs all internal manufacturing processes and operational workflows. Overseeing the production of lyophilized injections, the Chief Operating Officer ensures strict adherence to quality standards across all pharmaceutical facilities. This leadership role involves optimizing production efficiency to meet the high demand from major hospital chains throughout India. By integrating advanced manufacturing technologies, Nagesh Yarrabathina drives significant improvements in output capacity and product consistency. The Chief Operating Officer collaborates closely with the research and development teams to streamline the transition of new herbal and pharmaceutical products from laboratory development to full-scale commercial manufacturing. Through rigorous oversight of operational metrics, the Chief Operating Officer maintains the competitive edge of the company within the domestic market while supporting broader organizational goals for excellence in pharmaceutical manufacturing and distribution.

Ganesan Krishnamoorthy, the President, Supply Chain Management at Gufic Group, directs the logistics and distribution networks that connect pharmaceutical products to medical facilities. Overseeing the end-to-end supply chain, the President, Supply Chain Management ensures the timely delivery of critical antibiotics and antifungals to hospital chains across India. This leadership role involves managing complex inventory systems and vendor relationships to maintain a consistent supply of high-quality APIs. By optimizing distribution channels, Ganesan Krishnamoorthy drives operational efficiency and reduces lead times for essential medical supplies. The President, Supply Chain Management coordinates with manufacturing and sales teams to align inventory levels with market demand. Through the implementation of robust logistics strategies, the President, Supply Chain Management supports the company's commitment to reliable healthcare delivery. This focus on supply chain excellence facilitates the expansion of the company's footprint within the competitive pharmaceutical landscape.

Shekhar Aley, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare at Gufic Group, directs the commercial strategy for critical care and specialized therapeutic segments. Overseeing market penetration, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare ensures the effective promotion of antiviral and antifungal treatments to leading medical institutions. This leadership role involves analyzing regional market data to identify growth opportunities for the company's diverse product portfolio. By managing relationships with key healthcare providers, Shekhar Aley drives revenue growth and strengthens the brand presence across the Indian market. The President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare collaborates with the research team to communicate the value of new product launches to the medical community. Through the execution of targeted marketing campaigns, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare expands the reach of the company's innovative pharmaceutical solutions, ensuring alignment with the broader mission of improving patient outcomes.

Sunil Desai, the Chief Human Resources Officer at Gufic Group, architects the talent acquisition and organizational development strategies necessary for a leading pharmaceutical manufacturer. Overseeing workforce planning, the Chief Human Resources Officer ensures the recruitment of specialized scientific and technical personnel required for the production of complex APIs. This leadership role involves fostering a culture of innovation and compliance within the research and manufacturing divisions. By implementing comprehensive training programs, Sunil Desai drives employee engagement and professional growth across all regional operations. The Chief Human Resources Officer collaborates with executive leadership to align human capital strategies with the company's mission of providing advanced medical treatments. Through the development of performance management systems, the Chief Human Resources Officer optimizes team productivity and supports the achievement of corporate objectives. This focus on human capital ensures the organization maintains a highly skilled workforce capable of meeting evolving market demands.